|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 7/08 | (2006.01) |
| A61K 38/04 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3626729 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19199101.7 |
| Date of filing the European patent application | 2015-12-16 | |
| (97) | Date of publication of the European application | 2020-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation | 2021-10-25 |
| (30) | Number | Date | Country code |
| 201423016 | 2014-12-23 | GB | |
| 201462096165 P | 2014-12-23 | US | |
| 201501017 | 2015-01-21 | GB |
| (72) |
WEINSCHENK, Toni , DE
MAHR, Andrea , DE
FRITSCHE, Jens , DE
MÜLLER, Phillip , DE
WIEBE, Anita , DE
MISSEL, Sarah , DE
|
| (73) |
immatics Biotechnologies GmbH ,
Paul-Ehrlich-Straße 15, 72076 Tübingen,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji peptidai ir peptidų deriniai, skirti naudoti imunoterapijai prieš hepatoceliulinę karcinomą (HCK) ir kitų rūšių vėžį |
| NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS |
| Payment date | Validity (years) | Amount | |
| 2022-12-01 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-12-16 |